{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T01:03:52Z","timestamp":1782522232066,"version":"3.54.5"},"reference-count":77,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T00:00:00Z","timestamp":1672272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Diabetes is a metabolic disorder characterized by lower responsiveness of tissues to insulin and consequent large variations in circulating levels of glucose. This fluctuation has harmful effects as both hyperglycemia and hypoglycemia can be very injurious. The causes of diabetes are varied but the consequences are rather uniform. Dietary factors are important especially in adult onset type 2 diabetes (T2D) while type 1 diabetes (T1D) is characterized by having a stronger heritable component and involving autoimmune attach on pancreatic beta cells. This review is focused on the relation of the bacterial components found within the intestine, to the establishment and maintenance of diabetes. The precise composition of the gut microbiome is increasingly recognized as a factor in organismic health and its interaction with a variety of disease states has been described. This is especially marked in the case of diabetes since the nature of the diet is an important factor in establishing both the microbiome and the incidence of diabetes. The bidirectional nature of this relationship is discussed. The effects of disease that lead to altered microbiomal composition together with aberrant metabolic changes are also included. Emphasis is given to the important role of short chain fatty acids (SCFAs) as mediators of the microbiome-diabetes relation.<\/jats:p>","DOI":"10.3390\/ijms24010566","type":"journal-article","created":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T02:56:50Z","timestamp":1672282610000},"page":"566","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Relationships between Diabetes and the Intestinal Microbial Population"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5158-2993","authenticated-orcid":false,"given":"Stephen C.","family":"Bondy","sequence":"first","affiliation":[{"name":"Department of Medicine, Center for Occupational and Environmental Health, University of California, Irvine, CA 92697, USA"},{"name":"Department of Environmental & Occupational Health, University of California, Irvine, CA 92697, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"154712","DOI":"10.1016\/j.metabol.2021.154712","article-title":"Role of the gut microbiota in type 2 diabetes and related diseases","volume":"117","author":"Yang","year":"2021","journal-title":"Metabolism"},{"key":"ref_2","unstructured":"(2022, November 12). IDF Diabetes Atlas 2021\u201310th Edition. Available online: https:\/\/idf.org\/."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Ortega, M.A., Fraile-Mart\u00ednez, O., Naya, I., Garc\u00eda-Honduvilla, N., \u00c1lvarez-Mon, M., Buj\u00e1n, J., and De La Torre, B. (2020). Type 2 Diabetes Mellitus Associated with Obesity (Diabesity). The Central Role of Gut Microbiota and Its Translational Applications. Nutrients, 12.","DOI":"10.3390\/nu12092749"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41574-019-0254-y","article-title":"The heterogeneous pathogenesis of type 1 diabetes mellitus","volume":"15","author":"Ilonen","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/cmi.2017.57","article-title":"Microbiota or short-chain fatty acids: Which regulates diabetes?","volume":"15","author":"Kim","year":"2017","journal-title":"Cell Mol. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.3389\/fgene.2019.01329","article-title":"The Epigenetic Connection Between the Gut Microbiome in Obesity and Diabetes","volume":"10","author":"Sharma","year":"2020","journal-title":"Front. Genet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2337\/dc18-0288","article-title":"Identical and Nonidentical Twins: Risk and Factors Involved in Development of Islet Autoimmunity and Type 1 Diabetes","volume":"42","author":"Triolo","year":"2018","journal-title":"Diabetes Care"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1017\/thg.2015.83","article-title":"The Concordance and Heritability of Type 2 Diabetes in 34,166 Twin Pairs from International Twin Registers: The Discordant Twin (DISCOTWIN) Consortium","volume":"18","author":"Willemsen","year":"2015","journal-title":"Twin Res. Hum. Genet."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3389\/fendo.2019.00451","article-title":"Type 2 Diabetes: How Much of an Autoimmune Disease?","volume":"10","author":"Prattichizzo","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/obr.12214","article-title":"Preterm birth and risk of type 1 and type 2 diabetes: Systematic review and meta-analysis","volume":"15","author":"Li","year":"2014","journal-title":"Obes. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/jdi.13576","article-title":"\u03b2-Cell failure in diabetes: Common susceptibility and mechanisms shared between type 1 and type 2 diabetes","volume":"12","author":"Ikegami","year":"2021","journal-title":"J. Diabetes Investig."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.2337\/dc20-2834","article-title":"Latent Autoimmune Diabetes of Adults (LADA) Is Likely to Represent a Mixed Population of Autoimmune (Type 1) and Nonautoimmune (Type 2) Diabetes","volume":"44","author":"Jones","year":"2021","journal-title":"Diabetes Care"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1042\/BCJ20160510","article-title":"Introduction to the human gut microbiota","volume":"474","author":"Thursby","year":"2017","journal-title":"Biochem. J."},{"key":"ref_14","first-page":"1548","article-title":"The role of gut microbiota in mediating obesity and diabetes mellitus","volume":"24","author":"Pitocco","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"102590","DOI":"10.1016\/j.ebiom.2019.11.051","article-title":"Role of gut microbiota in type 2 diabetes pathophysiology","volume":"51","author":"Gurung","year":"2020","journal-title":"EBioMedicine"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s40200-022-01081-5","article-title":"Role of butyrogenic Firmicutes in type-2 diabetes","volume":"21","author":"James","year":"2022","journal-title":"J. Diabetes Metab. Disord."},{"key":"ref_17","first-page":"1322447","article-title":"Gut microbial diversity in health and disease: Experience of healthy Indian subjects, and colon carcinoma and inflammatory bowel disease patients","volume":"28","author":"Bamola","year":"2017","journal-title":"Microb. Ecol. Health Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1039\/C8FO01296B","article-title":"Microbiota-accessible pectic poly- and oligosaccharides in gut health","volume":"9","author":"Tingirikari","year":"2018","journal-title":"Food Funct."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1824563","DOI":"10.1080\/19490976.2020.1824563","article-title":"Conserved anti-inflammatory effects and sensing of butyrate in zebrafish","volume":"12","author":"Cholan","year":"2020","journal-title":"Gut Microbes"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e3043","DOI":"10.1002\/dmrr.3043","article-title":"Gut microbiome in type 1 diabetes: A comprehensive review","volume":"34","author":"Zheng","year":"2018","journal-title":"Diabetes\/Metab. Res. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"958218","DOI":"10.3389\/fendo.2022.958218","article-title":"Gut microbiota: A new target for T2DM prevention and treatment","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Coppola, S., Avagliano, C., Calignano, A., and Canani, R.B. (2021). The Protective Role of Butyrate against Obesity and Obesity-Related Diseases. Molecules, 26.","DOI":"10.3390\/molecules26030682"},{"key":"ref_23","first-page":"1165","article-title":"The effects of inflammation, aging and oxidative stress on the pathogenesis of diabetes mellitus (type 2 diabetes). Diabetes Metab. Syndr","volume":"13","author":"Halim","year":"2019","journal-title":"Clin. Res. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.3748\/wjg.v12.i23.3729","article-title":"Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-\u03baB activation","volume":"12","author":"Riedel","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2174\/1573399815666190206162143","article-title":"The Gut Microbiome, Lactobacillus acidophilus; Relation with Type 2 Diabetes Mellitus","volume":"15","author":"Halawa","year":"2019","journal-title":"Curr. Diabetes Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/jdi.12863","article-title":"Effects of probiotic supplements on insulin resistance in gestational diabetes mellitus: A double-blind randomized controlled trial","volume":"10","author":"Kijmanawat","year":"2018","journal-title":"J. Diabetes Investig."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"934695","DOI":"10.3389\/fimmu.2022.934695","article-title":"Akkermansia muciniphila and Gut Immune System: A Good Friendship That Attenuates Inflammatory Bowel Disease, Obesity, and Diabetes","volume":"13","author":"Rodrigues","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e2100536","DOI":"10.1002\/advs.202100536","article-title":"Decreased Abundance of Akkermansia muciniphila Leads to the Impairment of Insulin Secretion and Glucose Homeostasis in Lean Type 2 Diabetes","volume":"8","author":"Zhang","year":"2021","journal-title":"Adv. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00281-014-0454-4","article-title":"The gut microbiota and inflammatory bowel disease","volume":"37","author":"Matsuoka","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"571731","DOI":"10.3389\/fimmu.2020.571731","article-title":"Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes","volume":"11","author":"Scheithauer","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/ped.12243","article-title":"Differences in the gut microbiota of healthy children and those with type 1 diabetes","volume":"56","author":"Soyucen","year":"2014","journal-title":"Pediatr. Int."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1875796","DOI":"10.1080\/19490976.2021.1875796","article-title":"Blautia-a new functional genus with potential probiotic properties?","volume":"13","author":"Liu","year":"2021","journal-title":"Gut Microbes"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"105094","DOI":"10.1016\/j.jff.2022.105094","article-title":"Health benefits of resistant starch: A review of the literature","volume":"93","author":"Bojarczuk","year":"2022","journal-title":"J. Funct. Foods"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Cheng, S.H., Yang, T.Y., Hsu, C.C., Wei, Y.H., Wu, C.C., and Tsai, Y.C. (2022). Lactobacillus&nbsp;paragasseri BBM171 Ameliorates Allergic Airway Inflammation Induced by Ovalbumin in Mice via Modulating the Th1\/Th2 Balance. Microorganisms, 10.","DOI":"10.3390\/microorganisms10102041"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1475-2891-13-60","article-title":"Gut microbiota, probiotics and diabetes","volume":"13","author":"Gomes","year":"2014","journal-title":"Nutr. J."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Rinninella, E., Raoul, P., Cintoni, M., Franceschi, F., Miggiano, G.A.D., Gasbarrini, A., and Mele, M.C. (2019). What Is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases. Microorganisms, 7.","DOI":"10.3390\/microorganisms7010014"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Stojanov, S., Berlec, A., and \u0160trukelj, B. (2020). The Influence of Probiotics on the Firmicutes\/Bacteroidetes Ratio in the Treatment of Obesity and Inflammatory Bowel disease. Microorganisms, 8.","DOI":"10.3390\/microorganisms8111715"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Larsen, N., Vogensen, F.K., Van Den Berg, F.W.J., Nielsen, D.S., Andreasen, A.S., Pedersen, B.K., Al-Soud, W.A., S\u00f8rensen, S.J., Hansen, L.H., and Jakobsen, M. (2010). Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0009085"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"511","DOI":"10.7150\/ijms.51164","article-title":"The Association of Targeted Gut Microbiota with Body Composition in Type 2 Diabetes Mellitus","volume":"18","author":"Hung","year":"2021","journal-title":"Int. J. Med Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.2337\/dc21-1957","article-title":"An Atypical Form of Diabetes Among Individuals with Low BMI","volume":"45","author":"Dasgupta","year":"2022","journal-title":"Diabetes Care"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4239\/wjd.v6.i4.613","article-title":"Lean diabetes mellitus: An emerging entity in the era of obesity","volume":"6","author":"George","year":"2015","journal-title":"World J. Diabetes"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Koh, H.-C.E., Cao, C., and Mittendorfer, B. (2022). Insulin Clearance in Obesity and Type 2 Diabetes. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23020596"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Magne, F., Gotteland, M., Gauthier, L., Zazueta, A., Pesoa, S., Navarrete, P., and Balamurugan, R. (2020). The Firmicutes\/Bacteroidetes Ratio: A Relevant Marker of Gut Dysbiosis in Obese Patients?. Nutrients, 12.","DOI":"10.3390\/nu12051474"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1926841","DOI":"10.1080\/19490976.2021.1926841","article-title":"Impact of type 1 diabetes on the composition and functional potential of gut microbiome in children and adolescents: Possible mechanisms, current knowledge, and challenges","volume":"13","author":"Mokhtari","year":"2021","journal-title":"Gut Microbes"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11892-017-0933-9","article-title":"Modulation of Type 1 Diabetes Risk by the Intestinal Microbiome","volume":"17","author":"Knip","year":"2017","journal-title":"Curr. Diabetes Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3936247","DOI":"10.1155\/2020\/3936247","article-title":"Gut Microbiota Profile in Patients with Type 1 Diabetes Based on 16S rRNA Gene Sequencing: A Systematic Review","volume":"2020","author":"Zhou","year":"2020","journal-title":"Dis. Markers"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ebiom.2019.06.031","article-title":"Microbiome and type 1 diabetes","volume":"46","author":"Siljander","year":"2019","journal-title":"Ebiomedicine"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"9367404","DOI":"10.1155\/2019\/9367404","article-title":"The Interplay between Immune System and Microbiota in Diabetes","volume":"2019","author":"Moffa","year":"2019","journal-title":"Mediat. Inflamm."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3389\/fnins.2018.00725","article-title":"Inflammation and Gut-Brain Axis During Type 2 Diabetes: Focus on the Crosstalk Between Intestinal Immune Cells and Enteric Nervous System","volume":"12","author":"Bessac","year":"2018","journal-title":"Front. Neurosci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e1277","DOI":"10.6061\/clinics\/2020\/e1277","article-title":"Type 2 diabetes mellitus-related environmental factors and the gut microbiota: Emerging evidence and challenges","volume":"75","author":"Liu","year":"2020","journal-title":"Clinics"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000492853","article-title":"Short-Chain Fatty Acids Manifest Stimulative and Protective Effects on Intestinal Barrier Function Through the Inhibition of NLRP3 Inflammasome and Autophagy","volume":"49","author":"Feng","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1210\/jc.2019-00481","article-title":"Effect of Prebiotic on Microbiota, Intestinal Permeability, and Glycemic Control in Children with Type 1 Diabetes","volume":"104","author":"Ho","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1126\/science.aar3318","article-title":"Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection","volume":"359","author":"Thaiss","year":"2018","journal-title":"Science"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1297\/cpe.28.43","article-title":"Prediction and prevention of type 1 diabetes in children","volume":"28","author":"Chiarelli","year":"2019","journal-title":"Clin. Pediatr. Endocrinol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"632335","DOI":"10.3389\/fendo.2021.632335","article-title":"Modulating the Microbiota as a Therapeutic Intervention for Type 2 Diabetes","volume":"12","author":"Huda","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s13238-020-00814-7","article-title":"The role of the gut microbiome and its metabolites in metabolic diseases","volume":"12","author":"Wu","year":"2021","journal-title":"Protein Cell"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12967-017-1175-y","article-title":"Influence of diet on the gut microbiome and implications for human health","volume":"15","author":"Singh","year":"2017","journal-title":"J. Transl. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/advances\/nmx009","article-title":"Butyrate: A Double-Edged Sword for Health?","volume":"9","author":"Liu","year":"2018","journal-title":"Adv. Nutr."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e72171","DOI":"10.7554\/eLife.72171","article-title":"Short-chain fatty acids activate acetyltransferase p300","volume":"10","author":"Thomas","year":"2021","journal-title":"eLife"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"102312","DOI":"10.1016\/j.jbc.2022.102312","article-title":"Butyrate inhibits IL-1\u03b2-induced inflammatory gene expression by suppression of NF-\u03baB activity in pancreatic beta cells","volume":"298","author":"Pedersen","year":"2022","journal-title":"J. Biol. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3920\/BM2020.0057","article-title":"Short chain fatty acids in human gut and metabolic health","volume":"11","author":"Blaak","year":"2020","journal-title":"Benef. Microbes"},{"key":"ref_62","first-page":"574","article-title":"Gut microbiome dysbiosis and increased intestinal permeability in children with islet autoimmunity and type 1 diabetes: A prospective cohort study. Pediatr","volume":"20","author":"Harbison","year":"2019","journal-title":"Diabetes"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1589\/jpts.27.2365","article-title":"Effects of combined aerobic and resistance training on the glycolipid metabolism and inflammation levels in type 2 diabetes mellitus","volume":"27","author":"Liu","year":"2015","journal-title":"J. Phys. Ther. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3","DOI":"10.23736\/S0026-4806.18.05589-1","article-title":"Effects of chronic exercise on gut microbiota and intestinal barrier in human with type 2 diabetes","volume":"110","author":"Pasini","year":"2019","journal-title":"Minerva Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3831972","DOI":"10.1155\/2017\/3831972","article-title":"Exercise Modifies the Gut Microbiota with Positive Health Effects","volume":"2017","author":"Monda","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Yun, E.-J., Imdad, S., Jang, J., Park, J., So, B., Kim, J.-H., and Kang, C. (2022). Diet Is a Stronger Covariate than Exercise in Determining Gut Microbial Richness and Diversity. Nutrients, 14.","DOI":"10.3390\/nu14122507"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1210\/endrev\/bnaa023","article-title":"Cellular and Molecular Mechanisms of Metformin Action","volume":"42","author":"LaMoia","year":"2020","journal-title":"Endocr. Rev."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s42000-019-00093-w","article-title":"Metformin and gut microbiota: Their interactions and their impact on diabetes","volume":"18","author":"Vallianou","year":"2019","journal-title":"Hormones (Athens)"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/s41591-018-0222-4","article-title":"Gut microbiota and intestinal FXR mediate the clinical benefits of metformin","volume":"24","author":"Sun","year":"2018","journal-title":"Nat. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature15766","article-title":"Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota","volume":"528","author":"Forslund","year":"2015","journal-title":"Nature"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Lee, C., Chae, S., Jo, S., Jerng, U., and Bae, S. (2021). The Relationship between the Gut Microbiome and Metformin as a Key for Treating Type 2 Diabetes Mellitus. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22073566"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Craciun, C.I., Neag, M.A., Catinean, A., Mitre, A.O., Rusu, A., Bala, C., Roman, G., Buzoianu, A.D., Muntean, D.M., and Craciun, A.E. (2022). The Relationships between Gut Microbiota and Diabetes Mellitus, and Treatments for Diabetes Mellitus. Biomedicines, 10.","DOI":"10.3390\/biomedicines10020308"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13098-020-00603-6","article-title":"Probiotics supplementation and insulin resistance: A systematic review","volume":"12","author":"Salles","year":"2020","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fcimb.2019.00455","article-title":"Promising Treatment for Type 2 Diabetes: Fecal Microbiota Transplantation Reverses Insulin Resistance and Impaired Islets","volume":"9","author":"Wang","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.3389\/fmicb.2017.01765","article-title":"Next-Generation Beneficial Microbes: The Case of Akkermansia muciniphila","volume":"8","author":"Cani","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/gutjnl-2020-323071","article-title":"Gut microbiota-derived metabolites as central regulators in metabolic disorders","volume":"70","author":"Agus","year":"2020","journal-title":"Gut"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"826268","DOI":"10.3389\/fimmu.2022.826268","article-title":"Mechanisms of Kwashiorkor-Associated Immune Suppression: Insights from Human, Mouse, and Pig Studies","volume":"13","author":"Michael","year":"2022","journal-title":"Front. Immunol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/1\/566\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:54:57Z","timestamp":1760147697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/1\/566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,29]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["ijms24010566"],"URL":"https:\/\/doi.org\/10.3390\/ijms24010566","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,29]]}}}